Transcriptional Regulation of Cancer Immune Checkpoints: Emerging Strategies for Immunotherapy by Simran Venkatraman, Jarek Meller, Suradej Hongeng, Rutaiwan Tohtong, Somchai Chutipongtanate

Get full text

Targeting MYC at the intersection between cancer metabolism and oncoimmunology by Simran Venkatraman, Brinda Balasubramanian, Chanitra Thuwajit, Jaroslaw Meller, Jaroslaw Meller, Jaroslaw Meller, Rutaiwan Tohtong, Somchai Chutipongtanate, Somchai Chutipongtanate

Get full text

Co-Clinical Trials: An Innovative Drug Development Platform for Cholangiocarcinoma by Brinda Balasubramanian, Simran Venkatraman, Kyaw Zwar Myint, Tavan Janvilisri, Kanokpan Wongprasert, Supeecha Kumkate, David O. Bates, Rutaiwan Tohtong

Get full text

In Silico Target Identification of Galangin, as an Herbal Flavonoid against Cholangiocarcinoma by Brinda Balasubramanian, Simran Venkatraman, Kyaw Zwar Myint, Sucheewin Krobthong, Patompon Wongtrakoongate, Jittiyawadee Sripa, Panthip Rattanasinganchan, Pornphimon Metheenukul, Rutaiwan Tohtong

Get full text

Author Correction: Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial-to-mesenchymal transition of cholangiocarcinoma cells by Kittiya Islam, Brinda Balasubramanian, Simran Venkatraman, Parichut Thummarati, Janpen Tunganuntarat, Nut Phueakphud, Phongthon Kanjanasirirat, Tanawadee Khumpanied, Pornparn Kongpracha, Yingpinyapat Kittirat, Rutaiwan Tohtong, Tavan Janvilisri, Patompon Wongtrakoongate, Suparerk Borwornpinyo, Nisana Namwat, Tuangporn Suthiphongchai

Get full text

Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells by Kittiya Islam, Brinda Balasubramanian, Simran Venkatraman, Parichut Thummarati, Janpen Tunganuntarat, Nut Phueakphud, Phongthon Kanjanasirirat, Tanawadee Khumpanied, Pornparn Kongpracha, Yingpinyapat Kittirat, Rutaiwan Tohtong, Tavan Janvilisri, Patompon Wongtrakoongate, Suparerk Borwornpinyo, Nisana Namwat, Tuangporn Suthiphongchai

Get full text

CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in <i>Opisthorchis viverrini</i>-Associated Cholangiocarcinoma via Nrf2... by Jinchutha Duangdara, Boonyakorn Boonsri, Apinya Sayinta, Kittiya Supradit, Pakpoom Thintharua, Supeecha Kumkate, Chinnawut Suriyonplengsaeng, Noppadol Larbcharoensub, Somkit Mingphruedhi, Narongsak Rungsakulkij, Paramin Muangkaew, Pongsatorn Tangtawee, Watoo Vassanasiri, Wikran Suragul, Tavan Janvilisri, Rutaiwan Tohtong, David O. Bates, Kanokpan Wongprasert

Get full text

Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma by Kyaw Zwar Myint, Mireia Sueca-Comes, Pamela Collier, Brinda Balasubramanian, Simran Venkatraman, John Gordan, Abed M. Zaitoun, Abhik Mukherjee, Abhik Mukherjee, Arvind Arora, Arvind Arora, Noppadol Larbcharoensub, Chinnawut Suriyonplengsaeng, Kanokpan Wongprasert, Tavan Janvilisri, Tavan Janvilisri, Dhanny Gomez, Anna M. Grabowska, Rutaiwan Tohtong, David O. Bates, Kiren Yacqub-Usman

Get full text

Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation by Kyaw Zwar Myint, Brinda Balasubramanian, Simran Venkatraman, Suchada Phimsen, Supisara Sripramote, Jeranan Jantra, Chaiwat Choeiphuk, Somkit Mingphruedhi, Paramin Muangkaew, Narongsak Rungsakulkij, Pongsatorn Tangtawee, Wikran Suragul, Watoo Vassanasiri Farquharson, Kanokpan Wongprasert, Somchai Chutipongtanate, Pimtip Sanvarinda, Marisa Ponpuak, Naravat Poungvarin, Tavan Janvilisri, Tuangporn Suthiphongchai, Kiren Yacqub-Usman, Anna M. Grabowska, David O. Bates, Rutaiwan Tohtong

Get full text